Impairment of Nrf2- and nitrergic-mediated gastrointestinal motility in an MPTP mouse model of Parkinson's disease.

Journal article

BACKGROUND:Gastrointestinal (GI) motility dysfunction is the most common non-motor symptom of Parkinson's disease (PD). Studies have indicated that GI motility functions are impaired before the onset of PD.

AIMS:To investigate the underlying mechanism of PD-induced GI dysmotility in MPTP (1-methyl 4-phenyl 1,2,3,6-tetrahydropyridine)-induced animal model.

METHODS:C57BL/6 mice were administered with or without a selective dopamine neurotoxin, MPTP, to induce parkinsonian symptoms. In addition to in vivo studies, in vitro experiments were also conducted in colon specimens using l-methyl-4-phenylpyridinium (MPP+), a metabolic product of MPTP. Gastric emptying, colon motility, nitrergic relaxation, and western blot experiments were performed as reported.

RESULTS:MPTP-induced PD mice showed decreased expression of nuclear factor erythroid 2-related factor (Nrf2) and its target phase II genes in gastric and colon neuromuscular tissues. Decreased levels of tetrahydrobiopterin (BH4, a critical cofactor for nNOS dimerization) associated with uncoupling of nNOS in gastric and colon tissues exposed to MPTP. Impaired enteric nitrergic system led to delayed gastric emptying and slower colonic motility compared to the control mice. In vitro results in colon specimens confirm that activation of Nrf2 restored MPP+-induced suppression of alpha-synuclein, tyrosine hydroxylase (TH), Nrf2, and heme oxygenase-1. In vitro exposure to L-NAME [N(w)-nitro-L-arginine methyl ester], a NOS synthase inhibitor, reduced protein expression of TH in colon tissue homogenates.

CONCLUSIONS:Loss of Nrf2/BH4/nNOS expression in PD impairs antioxidant gene expression, which deregulates NO synthesis, thereby contributing to the development of GI dysmotility and constipation. Nitric oxide appears to be important to maintain dopamine synthesis in the colon.

Authors: Sampath, C; Kalpana, R; Ansah, T; Charlton, C; Hale, A

• Publication status: Published
• Peer review status: Peer reviewed
• Publisher: Springer
• Journal: Digestive Diseases and Sciences
• Publication date: 2019-06-11
• Acceptance date: 2019-05-31
• DOI: 10.1007/s10620-019-05693-5
• EISSN: 1573-2568
• ISSN: 0163-2116
• Pmid: 31187328
• Language: English
• Keywords: parkinson’s disease; α-synuclein; Nrf2; nitric oxide synthase; antioxidants; tetrahydrobiopterin; tyrosine hydroxylase; gastrointestinal motility